Inhaling xenon ameliorates l -dopa-induced dyskinesia in experimental parkinsonism-Reference-Cited by-同舟云学术

Inhaling xenon ameliorates l -dopa-induced dyskinesia in experimental parkinsonism

Published:2018-05-14 Issue:10 Volume:33 Page:1632-1642
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Baufreton Jérôme¹²,Milekovic Tomislav³,Li Qin⁴,McGuire Steve⁴,Moraud Eduardo Martin³,Porras Grégory⁴,Sun Shiqi³,Ko Wai Kin D.⁴,Chazalon Marine¹²,Morin Stéphanie¹²,Normand Elisabeth⁵⁶,Farjot Géraldine⁷,Milet Aude⁷,Pype Jan⁷,Pioli Elsa⁴,Courtine Gregoire³,Bessière Baptiste⁷,Bezard Erwan¹²⁴

Affiliation:

1. Université de Bordeaux, Institut des Maladies Neurodégénératives; Bordeaux France

2. Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives; Bordeaux France

3. Center for Neuroprosthetics and Brain Mind Institute, School of Life Sciences, Swiss Federal Institute of Technology (EPFL); Lausanne Switzerland

4. Motac Neuroscience; UK-M15 6WE Manchester United Kingdom

5. Université de Bordeaux, Institut Interdisciplinaires des Neurosciences; Bordeaux France

6. Centre National de la Recherche Scientifique Unité Mixte de Recherche 5297, Institut Interdisciplinaires des Neurosciences; Bordeaux France

7. Air Liquide Healthcare, Paris-Saclay research center; Jouy-en-Josas France

Funder

Air Liquide Santé International

Michael J. Fox Foundation

LABEX

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.27404/fullpdf

Reference45 articles.

1. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease;Bastide;Prog Neurobiol,2015

2. Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies;Bezard;Nat Rev Neurosci,2001

3. Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap;Calabresi;Lancet Neurol,2010

4. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia;Picconi;Nat Neurosci,2003

5. The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the motor symptoms of Parkinson's disease;Fox;Mov Disord,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4′-fluorocannabidiol associated with capsazepine restrains L-DOPA-induced dyskinesia in hemiparkinsonian mice: Contribution of anti-inflammatory and anti-glutamatergic mechanisms;Neuropharmacology;2024-06

2. A spinal cord neuroprosthesis for locomotor deficits due to Parkinson’s disease;Nature Medicine;2023-11

3. The cellular mechanisms associated with the anesthetic and neuroprotective properties of xenon: a systematic review of the preclinical literature;Frontiers in Neuroscience;2023-07-14

4. Effects of hydrogen gas inhalation on L-DOPA-induced dyskinesia;Brain, Behavior, & Immunity - Health;2023-07

5. Noble gas and neuroprotection: From bench to bedside;Frontiers in Pharmacology;2022-11-29